Abstract
This chapter gives a short overview of the expected imaging appearance of postoperative findings, postoperative recurrence, and potential postoperative complications that may occur after treatment of tumors of the osseous spine. Furthermore, assessment of response to chemo- and radiotherapy is discussed. Magnetic resonance imaging (MRI), including morphological sequences, dynamic contrast-enhanced imaging, and diffusion-weighted imaging, is the preferred technique to differentiate expected postoperative changes such as edema and fibrosis from local recurrence. Complementary computed tomography (CT) may add information by demonstrating osteolysis, detection of chondroid calcifications in recurrent cartilage tumors of chordoma, and calcified osteoid matrix in recurrent osteosarcoma. Positron emission tomography (PET)/CT and WBMRI have a complementary role in the posttreatment evaluation of lymphoma. PET/CT also has a role in the evaluation of posttreatment response of plasmacytoma.
Complications such as damage to neural structures, flap reconstruction failure, CSF leak with formation of pseudomeningocele, vascular injury, wound-related complications such as tissue necrosis, wound dehiscence, hematomas, seromas, infections, and development of extensive fibrosis are also best evaluated on MRI. CT is, however, the mainstay for hardware and bone graft failure.
Mimickers of poor response to chemotherapy include early granulation tissue, bone marrow changes due to chemotherapy or irradiation, radiation necrosis, and insufficiency fractures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aghighi M, Boe J, Rosenberg J et al (2016) Three-dimensional radiologic assessment of chemotherapy response in Ewing sarcoma can be used to predict clinical outcome. Radiology 280:905–915
Albano D, Messina C, Gitto S et al (2019) Differential diagnosis of spine tumors—my favorite mistake. Semin Musculoskelet Radiol 23:26–35
Albano D, Micci G, Patti C et al (2021) Whole-body magnetic resonance imaging: current role in patients with lymphoma. Diagnostics 11:1007
Alothman M, Althobaity W, Asiri Y et al (2020) Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities. Insights Imaging 11(1):41
Ariyarante S, Jenko N, Iyengar KP et al (2023) Primary osseous malignancies of the spine. Diagnostics 13(12):2006
Asmar K, Saade C, Salman R et al (2020) The value of diffusion weighted imaging and apparent diffusion coefficient in primary osteogenic and Ewing sarcomas for the monitoring of response to treatment: initial experience. Eur J Radiol 124:108855
Baidya Kayal E, Kandasamy D, Khare K et al (2019) Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy. Eur J Radiol 119:108635
Bancroft LW (2011) Postoperative tumor imaging. Semin Musculoskelet Radiol 2011(15):425–438
Barrington SF, O’Doherty MJ (2003) Limitations of Pet for imaging lymphoma. Eur J Nucl Med Mol Imaging Suppl 1:S117–127
Barz M, Aftahy K, Janssen I et al (2021) Spinal manifestation of primary malignant (PLB) and secondary bone lymphoma (SLB). Curr Oncol 28(5):3891–3899
Bauckneht M, Capitanio S, Donegani MI et al (2019) Role of baseline and post-therapy 18F-FDG PET in the prognostic stratification of metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223. Cancers 12:31
Baur A, Huber A, Arbogast S et al (2001) Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humans. Eur Radiol 11:828–833
Baur-Melnyk A, Reiser MF (2009) Multiple myeloma. Semin Musculoskelet Radiol 13:111–119
Beaman FD, Bancroft LW, Peterson JJ et al (2006) Imaging characteristics of bone graft materials. Radiographics 26(2):373–388
Bhojwani N, Szpakowski P, Partovi S et al (2015) Diffusion-weighted imaging in musculoskeletal radiology—clinical applications and future directions. Quant Imaging Med Surg 5:740–753
Bloem JL, Vriens D, Krol ADG et al (2020) Therapy-related imaging findings in patients with sarcoma. Semin Musculoskelet Radiol 24:676–691
Bluemke DA, Fishman EK, Scott WW Jr (1994) Skeletal complications of radiation therapy. Radiographics 14:111–121
Bostel T, Nicolay NH, Welzel T et al (2018) Sacral insufficiency fractures after high-dose carbon-ion based radiotherapy of sacral chordomas. Radiat Oncol 13:154
Boutin RD, White LM, Laor T et al (2015) MRI findings of serous atrophy of bone marrow and associated complications. Eur Radiol 25:2771–2778
Brown KT, Rosental DI, Rosenberg A (1983) Case report 247. Post-radiation osteitis of the sacrum. Skeletal Radiol 10:269–272
Campanacci L, Sambri A, Medellin MR et al (2019) A new computerized tomography classification to evaluate response to denosumab in giant cell tumors in the extremities (2019) Acta Orthop Traumatol Turc 53:376–380
Capps GW, Fulcher AS, Szucs RA, Turner MA (1997) Imaging features of radiation-induced changes in the abdomen. Radiographics 17:1455–1473
Chan BY, Gill KG, Rebsamen SL, Nguyen JC (2016) MR imaging of pediatric bone marrow. Radiographics 36:1911–1930
Chaturvedi A (2021) Pediatric skeletal diffusion-weighted magnetic resonance imaging: Part 2: Current and emerging applications. Pediatr Radiol 51:1575–1588
Chen J, Li C, Tian Y et al (2019) Comparison of whole-body DWI and (18)F-FDG PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma. AJR Am J Roentgenol 213:514–523
Choi H, Charnsangavej C, Faria SC et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753–1759
Chokshi FH, Low M, Gibbs WN (2018) Conventional and advanced imaging of spine oncologic disease, nonoperative post-treatment effects and unique spinal conditions. Neurosurgery 82:1–23
Dietrich O, Biffar A, Reiser MF, Baur-Melnyk A (2009) Diffusion-weighted imaging of bone marrow. Semin Musculoskelet Radiol 13:134–144
Dyke JP, Panicek DM, Healey JH et al (2003) Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast enhanced MR imaging. Radiology 228:271–278
Eisenhauer EA, Therasseb P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247
Engellau J, Seeger L, Grimer R et al (2018) Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. World J Surg Oncol 16:191
Erlemann R, Sciuk J, Bosse A et al (1990) Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 75:791–796
Fayad LM, Jacobs MA, Carrino JA, Bluemke DA (2012) Musculoskeletal tumors: how to use anatomic, functional and metabolic MR techniques. Radiology 265:340–356
Fournier L, Ammari S, Thiam R, Cuénod CA (2014) Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson. Diagn Interv Imaging 95:689–703
Fox MG, Bancroft LW, Peterson JJ (2006) MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery. Am J Roentgenol 187:800–806
Franck P, Bernstein JL, Cohen LE et al (2018) Local muscle flaps minimize post-operative wound morbidity in patients with neoplastic disease of the spine. Clin Neurol Neurosurg 171:100–105
Frisch S, Timmermann B (2007) The evolving role of proton beam therapy for sarcomas. Clin Oncol 29:500–506
Garner HW, Kransdorf MJ (2016) Musculoskeletal sarcoma: update on imaging of the post-treatment patient. Can Assoc Radiol J 67:12–120
Garner HW, Kransdorf MJ, Peterson JJ (2011) Posttherapy imaging of musculoskeletal neoplasms. Posttherapy imaging of musculoskeletal neoplasms. Radiol Clin North Am 49(6):1307–1323
Griffiths HJ, Thompson RC, Nitke SJ et al (1997) Use of MRI in evaluating postoperative changes in patients with bone and soft tissue tumors. Orthopedics 20:215–220
Gu L, Madewell JE, Aslam R, Mujtba B (2019) The effects of granulocyte growth stimulating factor on MR images of bone marrow. Skeletal Radiol 48:209–218
Gupta S, Stinson ZS, Marco RA, Dormans JP (2018) Single stage en bloc resection of a recurrent metastatic osteosarcoma of the pediatric lumbar spine through multiple exposures—a novel approach. SICOT-J 4:32
Hao Y, An R, Xue Y (2021) Prognostic value of tumoral and peritumoral magnetic resonance parameters in osteosarcoma patients for monitoring chemotherapy response. Eur Radiol 31:3518–3529
Hartman RP, Sundaram M, Okuno SH, Sim FH (2004) Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies. AJR Am J Roentgenol 183:645–653
Hawk MW, Kim KD (2000) Review of spinal pseudomeningoceles and cerebrospinal fluid fistulas. Neurosurg Focus 9(1):e5
Henderson ER, Xu X, Pogue BW et al (2020) Osteosarcoma mineralization changes on radiographs have moderate correlation to chemotherapy response using bone subtraction methodology. Ann Jt 5:38
Henry TD, McCarville ME, Hoffer FA (2006) Diagnostic imaging of pediatric bone and soft tissue sarcomas. In: Pappo A (ed) Pediatric bone and soft tissue sarcomas. Springer, Berlin, pp 35–69
Herrera IH, Dela Presa RM, Gutierrez RG et al (2013) Evaluation of the post operative lumbar spine. Radiologia 55(1):12–23
Hillengass J, Moulopoulos LA, Delorme S et al (2017) Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group. Blood Cancer J 7:e599
Hoeben BA, Carrie C, Timmermann B et al (2019) Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE Radiotherapy Working Group. Lancet Oncol 20:e155–e166
Holscher HC, Bloem JL, Vanel D et al (1992) Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology 182:839–844
Hu Z, Wen S, Huo Z et al (2022) Current status and prospects of targeted therapy for osteosarcoma. Cells 11:3507
Huvos AG, Rosen G, Marcove RC (1977) Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 101:14–18
Hwang S, Lefkowitz R, Landa J et al (2009) Local changes in bone marrow at MRI after treatment of extremity soft tissue sarcoma. Skeletal Radiol 38:11–19
Inarejos Clemente EJ, Navarro OM, Navallas M et al (2022) Multiparametric MRI evaluation of bone sarcomas in children. Insights Imaging 13:33
Jain NK, Dao K, Ortiz AO (2014) Radiologic evaluation and management of postoperative paraspinal fluid collections. Neuroimaging Clin N Am 24(2):375–389
Jin C, Xie M, Liang W, Qian Y (2020) Lumbar vertebral osteoradionecrosis: a rare case report with 10-year follow-up and brief literature review. BMC Musculoskelet Disord 21:7
Johnson SA, Kumar A, Matasar MJ et al (2015) Imaging for staging and response assessment in lymphoma. Radiology 276:323–338
Kattapuram SV, Rosol MS, Rosenthal DI et al (1999) Magnetic resonance imaging features of allografts. Skeletal Radiol 28:383–389
Kayal EB, Alampally JT, Sharma R et al (2023) Chemotherapy response evaluation using diffusion weighted MRI in Ewing sarcoma: a single center experience. Acta Radiol 64:1508–1517
Kim Y, Lee SK, Kim JY, Kim JH (2023) Pitfalls of diffusion-weighted imaging: clinical utility of T2-shine-through and T2-black-out for musculoskeletal diseases. Diagnostics 13(9):1647
Klish MD, Watson GA, Shrieve DC et al (2004) Radiation and intensity-modulated radiotherapy for metastatic spine tumors. Neurosurg Clin N Am 15(4):481–490
Koutoulidis V, Fontara S, Terpos E et al (2017) Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse MR imaging pattern in patients with multiple myeloma. Radiology 282:484–493
Koutoulidis V, Terpos E, Papanikolaou N et al (2022) Comparison of MRI features of fat fraction and ADC for early treatment response assessment in participants with multiple myeloma. Radiology 304:137–144
Kubo T, Furuta T, Jahan MP et al (2016) Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma. Systematic review and metaanalysis. Skeletal Radiol 45:1235–1288
Kubo T, Furuta T, Johan MP et al (2017) Value of diffusion-weighted imaging for evaluating chemotherapy response in osteosarcoma: a meta-analysis. Mol Clin Oncol 7:88–92
Latifoltojar A, Hall-Craggs M, Bainbrigde A et al (2017) Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction. Eur Radiol 27:5325–5336
Laux CJ, Brzaczy G, Weber M et al (2015) Tumor response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome. Int Orthop 39:97–104
Lecouvet FE, Vekemans MC, Van Den Berghe T et al (2022) Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT. Skeletal Radiol 51(1):59–80
Ledermann HP, Schweitzer ME, Morrison ME (2002) Nonenhancing tissue on MR imaging of pedal infection: characterization of necrotic tissue and associated limitations for diagnosis of osteomyelitis and abscess. AJR Am J Roentgenol 178(1):215–222
Lee J, Yoo YH, Lee S et al (2018) Gelatinous transformation of bone marrow mimicking malignant marrow-replacing lesion on magnetic resonance imaging in a patient without underlying devastating disease. iMRI 22:50–55
Lee SH, Kwok KY, Wong SM et al (2022) Chordoma at the skull base, spine and sacrum: a pictorial essay. J Clin Imaging Sci 12:44
Lejoly M, Van Den Berghe T, Creytens D et al (2024) Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation. Skeletal Radiol 53(2):353–364
Li Z, Guo L, Zhang P et al (2023) A systematic review of perioperative complications in en bloc resection of spinal tumors. Global Spine J 13:812
Lim CY, Ong KO (2013) Imaging of musculoskeletal lymphoma. Cancer Imaging 14:448–457
Lin E, Scognamiglio T, Zhao Y et al (2018) Prognostic implications of gadolinium enhancement of skull base chordomas. AJNR Am J Neuroradiol 39(8):1509–1514
Liu X, Duan Z, Fang S, Wang S (2024) Imaging assessment of the efficacy of chemotherapy in primary malignant bone tumors: recent advances in qualitative and quantitative magnetic resonance imaging and radiomics. J Magn Reson Imaging 59(1):7–31
Matsumoto Y, Fukumitsu N, Ishikawa H, Nakai K, Sakurai H (2021) A critical review of radiation therapy: from particle beam therapy (proton, carbon and BNCT) to beyond. J Pers Med 11:825
Mayerhoefer ME, Archibald SJ, Messiou C et al (2020) MRI and PET/MRI in hematologic malignancies. J Magn Reson Imaging 51:1325–1335
Meixel AJ, Hauswald H, Delorme S, Jobke B (2018) From radiation osteitis to osteoradionecrosis: incidence and MR morphology of radiation-induced sacral pathologies following pelvic radiotherapy. Eur Radiol 28:3550–3559
Mule S, Reizine E, Blanc-Durand P et al (2020) Whole-body functional MRI and PET/MRI in multiple myeloma. Cancers 12:3155
National Institute for Health and Care Excellence NICE Myeloma (2016) Diagnosis and management. https://www.nice.org.uk/guidance/ng35/chapter/Recommendations
Noebauer-Huhmann IM, Chaudhary SR, Papakonstantinou O et al (2020) Soft tissue sarcoma follow-up imaging: strategies to distinguish post-treatment changes from recurrence. Semin Musculoskelet Radiol 24:627–644
O’Sallivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft tissue sarcoma of the limbs: a randomized trial. Lancet 29(359):2235–2241
Oguro S, Okuda S, Sugiura H et al (2018) Giant cell tumor of the bone: change in image features after denosumab administration. Magn Reson Med Sci 17:325–333
Oka K, Yakushiji T, Sato H et al (2010) The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol 39:141–146
Ollivier L, Leclere J, Vanel D et al (1991) Femoral infarction following intraarterial chemotherapy for osteosarcoma of the leg: a possible pitfall in magnetic resonance imaging. Skeletal Radiol 20:329–332
Ollivier L, Gerber S, Vanel D, Brisse H, Leclere J (2006) Improving the interpretation of bone marrow imaging in cancer patients. Cancer Imaging 6:194–198
Papakonstantinou O, Isaac A, Dalili D, Noebauer-Huhmann IM (2019) T2 hypointense tumors and tumor like lesions. Semin Musculoskelet Radiol 23:58–75
Parmeggiani A, Miceli M, Errani C, Facchini G (2021) State of the art and new concepts in giant cell tumor of the bone: imaging features and tumor characteristics. Cancers 13:6298
Patel SR (2000) Radiation-induced sarcoma. Curr Treat Options Oncol 1:258–261
Radcliff K, Morrison WB, Kepler C et al (2016) Distinguishing pseudomeningocele, epidural hematoma and postoperative infection on postoperative MRI. Clin Spine Surg 29:E471
Rahmouni A, Meigan M, Diine M et al (2003) MRI and PET of bone lymphoproliferative diseases. Cancer Imaging 3:122–125
Reinert CP, Krieg EM, Bosmuller H, Horger M (2020) Mid-term response assessment in multiple myeloma using a texture analysis approach on dual energy-CT-derived bone marrow images—a proof of principle study. Eur J Radiol 131:109214
Richardson ML, Zink-Brody GC, Patten RM et al (1996) MR characterization of post-irradiation soft tissue edema. Skeletal Radiol 25:537–543
Roberge D, Skamene T, Nahal A et al (2010) Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma. Radiother Oncol 97:404–440
Rodallec MH, Feydy A, Larousserie F et al (2008) Diagnostic imaging of solitary tumors of the spine: what to do and say. Radiographics 28:1019–1041
Saleh MM, Abdelrahman TM, Madney Y et al (2020) Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing’s sarcoma. Br J Radiol 93(1115):20200257
Santos P, Peck KK, Arevalo-Perez J et al (2017) T1-weighted dynamic contrast-enhanced MR perfusion imaging characterizes tumor response to radiation therapy in chordoma. Am J Neuroradiol 38:2210–2216
Sasaki T, Moritani T, Belay A et al (2018) Role of apparent diffusion coefficient as a predictor of tumor progression in patients with chordoma. Am J Neuroradiol 39:1316–1321
Schilling AT, Ehresman J, Huq S et al (2020) Risk factors for wound related complications after surgery for primary and metastatic spine tumors: a systematic review and metaanalysis. World Neurosurg 141:467–478
Schultheiss TE (2008) The radiation dose-response of the human spinal cord. Int J Radiat Oncol Biol Phys 71:1455–1459
Schulze M, Weisel K, Grandjean C et al (2014) Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study. AJR Am J Roentgenol 202(1):170–179
Seam P, Juweid ME, Cheson BD (2007) The role of FDG-PET scans in patients with lymphoma. Blood 110:3507–35016
Shapeero LG, De Visschere PJ, Verstraete KL et al (2008) Post-treatment complications of soft tissue tumors. Eur J Radiol 69(2):209–221
Sheppard DG, Libshitz HI (2001) Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol 56:22–29
Son HM, Yoo HJ, Hong SH et al (2022) Detection of soft tissue sarcoma recurrence: feasibility of ultrafast 3D Gradient-echo sequence in additional to contrast enhanced MRI to provide early-phase post contrast information. J Belg Soc Radiol 106(51):1–9
Subhawong TK, Jacobs MA, Fayad LM (2014) Diffusion-weighted imaging for characterizing musculoskeletal lesions. Radiographics 34(5):1163–1177
Uhl M, Saueressig U, Koehler G et al (2006) Evaluation of tumor necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol 36:1306–1311
Verstraete K (2009) Assessment of response to chemotherapy and radiotherapy. In: Davies AM, Sundaram M, James SLJ (eds) Imaging of bone tumors and tumor-like lesions. Techniques and applications. Springer, Berlin
Vilanova JC, Baleato-Gonzalez S, Romero M et al (2016) Assessment of musculoskeletal malignancies with functional MR imaging. Magn Reson Imaging Clin N Am 24:239–259
Wahl RL, Jacene H, Kasamon Y et al (2009) From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med 50:122S–150S
Wang CS, Du LJ, Si MJ et al (2013) Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study. PloS One 26:72679
Wardelmann E, Haas RL, Bovee JVMG et al (2016) Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting. Eur J Cancer 53:84–95
Yamamoto Y, Taoka T, Nakamine H (2009) Superior clinical impact of FDG-PET compared to MRI for the follow-up of a patient with sacral lymphoma. J Clin Exp Hematopathol 49:109–115
Yamazaki T, McLoughlin GS, Patel S et al (2009) Feasibility and safety of en bloc resection for primary spine tumors: a systematic review by the spine oncology group. Spine (Phila Pa 1976) 34(22 Suppl):S31
Yeom KW, Lober RM, Mobley BC et al (2013) Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma. Am J Neuroradiol 34:1056–1061
Young PM, Berquist TH, Bancroft LW, Peterson JJ (2007) Complications of spinal instrumentation. Radiographics 27(3):775–789
Zeng YN, Zhang BT, Song T et al (2022) The clinical value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) semi-quantitative parameters in monitoring neoadjuvant chemotherapy response of osteosarcoma. Acta Radiol 63:1077–1085
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Papakonstantinou, O., Chaudhary, S.R., Pusitz, S., Nöebauer-Huhmann, IM. (2024). Assessment of Locally Recurrent Disease, Response to Chemo- and Radiotherapy, and Special Considerations. In: Ladeb, M.F., Vanhoenacker, F. (eds) Imaging of Primary Tumors of the Osseous Spine. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2024_478
Download citation
DOI: https://doi.org/10.1007/174_2024_478
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-56885-5
Online ISBN: 978-3-031-56886-2
eBook Packages: MedicineMedicine (R0)